JP2021516991A5 - - Google Patents
Info
- Publication number
- JP2021516991A5 JP2021516991A5 JP2020568945A JP2020568945A JP2021516991A5 JP 2021516991 A5 JP2021516991 A5 JP 2021516991A5 JP 2020568945 A JP2020568945 A JP 2020568945A JP 2020568945 A JP2020568945 A JP 2020568945A JP 2021516991 A5 JP2021516991 A5 JP 2021516991A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- amino acid
- composition
- compound
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023222587A JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Ｃｐｇアンフィフィル及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637824P | 2018-03-02 | 2018-03-02 | |
| US62/637,824 | 2018-03-02 | ||
| PCT/US2019/020398 WO2019169328A1 (en) | 2018-03-02 | 2019-03-01 | Cpg amphiphiles and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023222587A Division JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Ｃｐｇアンフィフィル及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021516991A JP2021516991A (ja) | 2021-07-15 |
| JP2021516991A5 true JP2021516991A5 (https=) | 2022-03-09 |
| JPWO2019169328A5 JPWO2019169328A5 (https=) | 2022-03-09 |
Family
ID=67805576
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020568945A Pending JP2021516991A (ja) | 2018-03-02 | 2019-03-01 | Ｃｐｇアンフィフィル及びその使用 |
| JP2023222587A Pending JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Ｃｐｇアンフィフィル及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023222587A Pending JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Ｃｐｇアンフィフィル及びその使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US12247052B2 (https=) |
| EP (1) | EP3758712B1 (https=) |
| JP (2) | JP2021516991A (https=) |
| KR (2) | KR20250111403A (https=) |
| CN (2) | CN120249290A (https=) |
| AU (1) | AU2019227988B2 (https=) |
| BR (1) | BR112020017778A2 (https=) |
| CA (1) | CA3092693A1 (https=) |
| DK (1) | DK3758712T3 (https=) |
| ES (1) | ES3035198T3 (https=) |
| IL (1) | IL277101B2 (https=) |
| MA (1) | MA52434A (https=) |
| MX (1) | MX2020009150A (https=) |
| MY (1) | MY209484A (https=) |
| PL (1) | PL3758712T3 (https=) |
| PT (1) | PT3758712T (https=) |
| SA (1) | SA520420065B1 (https=) |
| SG (1) | SG11202008432XA (https=) |
| UA (1) | UA128863C2 (https=) |
| WO (1) | WO2019169328A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11696954B2 (en) | 2017-04-28 | 2023-07-11 | Exicure Operating Company | Synthesis of spherical nucleic acids using lipophilic moieties |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| BR112020017645A2 (pt) | 2018-03-02 | 2020-12-29 | Elicio Therapeutics Inc. | Compostos que incluem uma sequência kras mutante e um lipídio e usos dos mesmos |
| CN116507344A (zh) * | 2020-06-26 | 2023-07-28 | 伊莱西奥治疗有限公司 | 用于诱导针对冠状病毒的免疫应答的组合物和方法 |
| AU2021294342A1 (en) * | 2020-06-26 | 2023-02-23 | Elicio Therapeutics, Inc. | Compositions and methods for inducing an immune response against coronavirus |
| US20250134992A1 (en) * | 2021-08-16 | 2025-05-01 | Elicio Therapeutics, Inc. | Compositions containing polynucleotide amphiphiles and methods of use thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6168778B1 (en) * | 1990-06-11 | 2001-01-02 | Nexstar Pharmaceuticals, Inc. | Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes |
| AU2001268427B2 (en) | 2000-06-16 | 2007-03-29 | Glaxosmithkline Intellectual Property Limited | Antibodies that immunospecifically bind to blys |
| US8771702B2 (en) * | 2001-03-26 | 2014-07-08 | The Trustees Of The University Of Pennsylvania | Non-hemolytic LLO fusion proteins and methods of utilizing same |
| WO2005001116A1 (ja) * | 2003-06-17 | 2005-01-06 | Meiji Dairies Corporation | Toll様レセプター強制発現細胞の利用 |
| US9090673B2 (en) * | 2003-12-12 | 2015-07-28 | City Of Hope | Synthetic conjugate of CpG DNA and T-help/CTL peptide |
| CA2574090A1 (en) * | 2004-07-18 | 2006-12-21 | Coley Pharmaceutical Group, Ltd. | Methods and compositions for inducing innate immune responses |
| NZ575437A (en) | 2006-09-27 | 2012-02-24 | Coley Pharm Gmbh | Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity |
| EP2155889A4 (en) * | 2007-05-25 | 2010-06-16 | Centocor Ortho Biotech Inc | TOLL RECEPTOR 3 MODULATORS AND USES THEREOF |
| US20120087949A1 (en) * | 2008-12-19 | 2012-04-12 | University Of Florida Research Foundation, Inc. | Oligonucleotide micelles |
| ES2731343T3 (es) | 2009-05-19 | 2019-11-15 | Univ Miami | Composiciones, kits y métodos para presentación de antígenos in vitro, evaluación de eficacia de vacunas y evaluación de la inmunotoxicidad de productos biológicos y fármacos |
| WO2011036557A1 (en) * | 2009-09-22 | 2011-03-31 | The University Of British Columbia | Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles |
| AU2011227714B2 (en) | 2010-03-19 | 2014-09-04 | Takeda Pharmaceutical Company Limited | TFPI inhibitors and methods of use |
| KR20140005998A (ko) * | 2011-01-24 | 2014-01-15 | 안테리오스, 인코퍼레이티드 | 나노입자 조성물, 이의 제형, 및 그의 용도 |
| EP4427814A3 (en) | 2011-05-25 | 2024-11-20 | Camurus AB | Controlled release peptide formulations |
| CA2849705A1 (en) | 2011-09-23 | 2013-03-28 | Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa | Modified albumin-binding domains and uses thereof to improve pharmacokinetics |
| EP2908853B1 (en) | 2012-10-21 | 2018-12-05 | University Of Rochester | Thy1 (cd90) as a therapy to control adipose tissue accumulation |
| KR102109188B1 (ko) | 2013-04-01 | 2020-05-11 | 삼성전자주식회사 | 양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도 |
| AR095882A1 (es) * | 2013-04-22 | 2015-11-18 | Hoffmann La Roche | Terapia de combinación de anticuerpos contra csf-1r humano con un agonista de tlr9 |
| KR102100289B1 (ko) * | 2013-10-24 | 2020-04-13 | 주식회사 다이셀 | 은 나노 입자 함유 분산액의 제조 방법 및 은 나노 입자 함유 분산액 |
| JP2017532373A (ja) * | 2014-09-11 | 2017-11-02 | ヴェダントラ ファーマシューティカルズ，インコーポレーテッド | マルチラメラ脂質ベシクル組成物及び使用方法 |
| US10940201B2 (en) * | 2015-09-30 | 2021-03-09 | Shionogi & Co., Ltd. | Nucleic acid derivative having immunostimulatory activity |
| JP7197481B2 (ja) | 2016-11-30 | 2022-12-27 | アドバクシス， インコーポレイテッド | 反復性がん突然変異を標的とする免疫原性組成物およびその使用の方法 |
| CA3054172A1 (en) * | 2017-02-23 | 2018-08-30 | Alpha-O Peptides Ag | Self-assembling protein nanoparticles encapsulating immunostimulatory nucleid acids |
| BR112020017645A2 (pt) * | 2018-03-02 | 2020-12-29 | Elicio Therapeutics Inc. | Compostos que incluem uma sequência kras mutante e um lipídio e usos dos mesmos |
-
2019
- 2019-03-01 DK DK19761384.7T patent/DK3758712T3/da active
- 2019-03-01 JP JP2020568945A patent/JP2021516991A/ja active Pending
- 2019-03-01 CN CN202510413325.0A patent/CN120249290A/zh active Pending
- 2019-03-01 UA UAA202006353A patent/UA128863C2/uk unknown
- 2019-03-01 IL IL277101A patent/IL277101B2/en unknown
- 2019-03-01 CN CN201980028828.9A patent/CN112203663A/zh active Pending
- 2019-03-01 EP EP19761384.7A patent/EP3758712B1/en active Active
- 2019-03-01 WO PCT/US2019/020398 patent/WO2019169328A1/en not_active Ceased
- 2019-03-01 US US16/977,185 patent/US12247052B2/en active Active
- 2019-03-01 MY MYPI2020004499A patent/MY209484A/en unknown
- 2019-03-01 MX MX2020009150A patent/MX2020009150A/es unknown
- 2019-03-01 CA CA3092693A patent/CA3092693A1/en active Pending
- 2019-03-01 ES ES19761384T patent/ES3035198T3/es active Active
- 2019-03-01 PL PL19761384.7T patent/PL3758712T3/pl unknown
- 2019-03-01 AU AU2019227988A patent/AU2019227988B2/en active Active
- 2019-03-01 KR KR1020257023614A patent/KR20250111403A/ko active Pending
- 2019-03-01 SG SG11202008432XA patent/SG11202008432XA/en unknown
- 2019-03-01 KR KR1020207028281A patent/KR102837422B1/ko active Active
- 2019-03-01 BR BR112020017778-4A patent/BR112020017778A2/pt unknown
- 2019-03-01 MA MA052434A patent/MA52434A/fr unknown
- 2019-03-01 PT PT197613847T patent/PT3758712T/pt unknown
-
2020
- 2020-08-31 SA SA520420065A patent/SA520420065B1/ar unknown
-
2023
- 2023-12-28 JP JP2023222587A patent/JP2024045151A/ja active Pending
-
2025
- 2025-01-31 US US19/042,771 patent/US20250171507A1/en not_active Abandoned
- 2025-09-19 US US19/333,784 patent/US20260015390A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021516991A5 (https=) | ||
| JP7504464B2 (ja) | 核酸ワクチン | |
| JP7330590B2 (ja) | 水痘帯状疱疹ウイルス（ｖｚｖ）のための核酸ワクチン | |
| ES3005233T3 (en) | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof | |
| JP2021519595A (ja) | 新規ｒｓｖ ｒｎａ分子及びワクチン接種用組成物 | |
| JP2013532971A5 (https=) | ||
| KR20180096591A (ko) | 광범위 인플루엔자 바이러스 백신 | |
| IL317818A (en) | Oligonucleotides to reduce PD-L1 expression | |
| JP2024045151A (ja) | Ｃｐｇアンフィフィル及びその使用 | |
| JP2008056679A5 (https=) | ||
| JP2015529678A5 (https=) | ||
| AU2023414262A1 (en) | Polynucleotide molecule for preventing or treating hpv infection-related diseases | |
| JP2022507373A5 (https=) | ||
| JPWO2019169328A5 (https=) | ||
| JP2009538836A (ja) | 生物活性の精製ＨｓｐＥ７組成物 | |
| RU2229307C1 (ru) | Композиция рекомбинантных белков, способ получения такой композиции, фармацевтический набор реагентов для иммунотерапии и профилактической вакцинации опухолевых заболеваний аногенитальной сферы, способ иммунотерапии и профилактической вакцинации на его основе | |
| JPWO2019169332A5 (https=) | ||
| JP2012501351A5 (https=) | ||
| JP2011504108A5 (https=) | ||
| RU2823677C2 (ru) | Cpg амфифилы и их применения | |
| WO2025092908A1 (zh) | 治疗HPV感染相关疾病的mRNA疫苗 | |
| CN118021956A (zh) | 一种编码抗禽流感H7N9病毒抗体的mRNA及其制法和应用 | |
| HK40045177A (en) | Cpg amphiphiles and uses thereof | |
| HK40045177B (en) | Cpg amphiphiles and uses thereof | |
| HK40043266A (en) | Cpg amphiphiles and uses thereof |